Abstract
111P - Ceritinib Treatment of Patients (PTS) with Alk-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases: Ascend-1 Trial Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have